Canopy Growth Q2 revenue down 9% to $63M; adjusted EBITDA loss improves 54% to $5.5M

Canopy Growth Corp

2025-Q2 EPS reported -$3.08 vs consensus -$0.24 ▼ miss (-1184.9%)

Net revenue $63.0M, down 9% YoY; excluding divested businesses, up 3%.
Adjusted EBITDA loss $5.5M, improved 54% YoY; net loss from cont. ops $131.6M.
Canada medical revenue +16% YoY; Storz & Bickel +32% on Germany reform and US sales.
Early prepayment reduced secured term loan by US$100M; cash balance $231M.
Canopy USA closed Wana acquisition post-quarter; Acreage acquisition on track for H1 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.